These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10820001)

  • 1. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,).
    Ness S; Martin R; Kindler AM; Paetzel M; Gold M; Jensen SE; Jones JB; Strynadka NC
    Biochemistry; 2000 May; 39(18):5312-21. PubMed ID: 10820001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase.
    Strynadka NC; Martin R; Jensen SE; Gold M; Jones JB
    Nat Struct Biol; 1996 Aug; 3(8):688-95. PubMed ID: 8756327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and resistance in TEM beta-lactamase.
    Wang X; Minasov G; Blázquez J; Caselli E; Prati F; Shoichet BK
    Biochemistry; 2003 Jul; 42(28):8434-44. PubMed ID: 12859188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
    Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
    Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.
    Morandi S; Morandi F; Caselli E; Shoichet BK; Prati F
    Bioorg Med Chem; 2008 Feb; 16(3):1195-205. PubMed ID: 17997318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
    Ke W; Sampson JM; Ori C; Prati F; Drawz SM; Bethel CR; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2011 Jan; 55(1):174-83. PubMed ID: 21041505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
    Chen CC; Herzberg O
    Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases.
    Dzhekieva L; Adediran SA; Pratt RF
    Biochemistry; 2014 Oct; 53(41):6530-8. PubMed ID: 25302576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
    Rojas LJ; Taracila MA; Papp-Wallace KM; Bethel CR; Caselli E; Romagnoli C; Winkler ML; Spellberg B; Prati F; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1751-9. PubMed ID: 26729496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENDOR structural characterization of a catalytically competent acylenzyme reaction intermediate of wild-type TEM-1 beta-lactamase confirms glutamate-166 as the base catalyst.
    Mustafi D; Sosa-Peinado A; Makinen MW
    Biochemistry; 2001 Feb; 40(8):2397-409. PubMed ID: 11327860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
    Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boronic acid inhibitors of the class A β-lactamase KPC-2.
    Zhou J; Stapleton P; Haider S; Healy J
    Bioorg Med Chem; 2018 Jul; 26(11):2921-2927. PubMed ID: 29784271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
    Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
    Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases.
    Maveyraud L; Pratt RF; Samama JP
    Biochemistry; 1998 Feb; 37(8):2622-8. PubMed ID: 9485412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.